The Efficacy of a Probiotic Product on Acute Upper Respiratory Tract Infections (Common Cold) in Healthy Children

Acute Upper Respiratory Tract Infections (Common Cold) Clinical Trial

Official title: A Randomized, Double Blind, Placebo-controlled Study to Investigate the Effect of a Probiotic Product on Acute Upper Respiratory Tract Infections (Common Cold) in Healthy Children

Status Completed

Clinical Trial Summary

The aim of the present study is to test the efficacy of the combination of two probiotic bacteria in reducing the severity of upper respiratory tract infections (common cold) in healthy children attending day care or school. The probiotic bacteria used are Lactobacillus plantarum strain DSM 15312 and Lactobacillus paracasei DSM 13434 at a total dose of 1 x 10^9 CFU/tablet and day and will be consumed for a period of 12 weeks.

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Acute Upper Respiratory Tract Infections (Common Cold)
• Common Cold
• Communicable Diseases
• Infection
• Respiratory Tract Infections

• NCT number: NCT02640352
• Study type: Interventional
• Source: Probi AB
• Status: Completed
• Phase: N/A
• Start date: December 2015
• Completion date: September 2018